- Glidden, David;
- Grant, Robert;
- Marcus, JL;
- Glidden, DV;
- Mayer, KH;
- Liu, AY;
- Buchbinder, SP;
- Amico, KR;
- McMahan, V;
- Kallas, EG;
- Montoya-Herrera, O;
- Pilotto, J
Objective: Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) reduced HIV acquisition in the iPrEx trial among men who have sex with men and transgender women. Self-reported sexual risk behavior decreased overall, but